• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄芪甲苷通过 miR-378/TRAF5 信号通路抑制糖尿病肾病大鼠足细胞凋亡。

Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378/TRAF5 signaling pathway.

机构信息

Traditional Chinese Medicine Department, the Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China.

Traditional Chinese Medicine Department, the Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China.

出版信息

Life Sci. 2018 Aug 1;206:77-83. doi: 10.1016/j.lfs.2018.05.037. Epub 2018 May 22.

DOI:10.1016/j.lfs.2018.05.037
PMID:29792879
Abstract

AIMS

Apoptosis of podocytes plays a crucial role in diabetic nephropathy (DN) development, and astragaloside (AS-IV) has a significant impact on podocyte apoptosis. This study aims to explore the effect of AS-IV on diabetic nephropathy progression.

MATERIALS AND METHODS

The diabetic nephropathy model was established in rats with streptozotocin (STZ) injection. The albuminuria was examined by using the enzyme linked immunosorbent assay (ELISA). The expression of miR-378, tumor-necrosis factor (TNF) receptor (TNFR)-associated factor 5 (TRAF5) mRNA and protein was analyzed by qRT-PCR and western blot, respectively. Cell transfection was conducted for modulating endogenous expression of miR-378. Dual luciferase reporter assay was used to evaluate the interaction between miR-378 and TRAF5. The terminal deoxynucleotidy transferase dUTP nick end labeling (TUNEL) staining assay was performed for apoptosis detection.

KEY FINDINGS

AS-IV protected diabetic rats from developing into diabetic nephropathy. The expression of miR-378 was down-regulated in diabetic nephropathy rats, which was reversed by AS-IV. AS-IV enhanced the expression of miR-378 in podocytes treated with high glucose. MiR-378 negatively regulated TRAF5. AS-IV inhibited the expression of TRAF5 through miR-378. AS-IV suppressed apoptosis of podocytes via targeting miR-378.

SIGNIFICANCE

AS-IV suppresses apoptosis of the podocytes through the miR-378/TRAF5 signaling pathway, and thereby repressing diabetic nephropathy development.

摘要

目的

足细胞凋亡在糖尿病肾病(DN)的发生发展中起着关键作用,而黄芪甲苷(AS-IV)对足细胞凋亡有显著影响。本研究旨在探讨 AS-IV 对糖尿病肾病进展的影响。

材料与方法

采用链脲佐菌素(STZ)注射建立糖尿病肾病大鼠模型。通过酶联免疫吸附试验(ELISA)检测白蛋白尿。采用 qRT-PCR 和 Western blot 分别分析 miR-378、肿瘤坏死因子(TNF)受体(TNFR)相关因子 5(TRAF5)mRNA 和蛋白的表达。通过细胞转染调节内源性 miR-378 的表达。采用双荧光素酶报告基因实验评估 miR-378 与 TRAF5 的相互作用。采用末端脱氧核苷酸转移酶 dUTP 缺口末端标记(TUNEL)染色法检测细胞凋亡。

主要发现

AS-IV 可防止糖尿病大鼠发生糖尿病肾病。糖尿病肾病大鼠中 miR-378 的表达下调,AS-IV 可使其逆转。AS-IV 增强了高糖处理的足细胞中 miR-378 的表达。miR-378 负调控 TRAF5。AS-IV 通过 miR-378 抑制 TRAF5 的表达。AS-IV 通过靶向 miR-378 抑制足细胞凋亡。

意义

AS-IV 通过 miR-378/TRAF5 信号通路抑制足细胞凋亡,从而抑制糖尿病肾病的发生发展。

相似文献

1
Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378/TRAF5 signaling pathway.黄芪甲苷通过 miR-378/TRAF5 信号通路抑制糖尿病肾病大鼠足细胞凋亡。
Life Sci. 2018 Aug 1;206:77-83. doi: 10.1016/j.lfs.2018.05.037. Epub 2018 May 22.
2
Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats.黄芪甲苷IV/长链非编码RNA-TUG1/肿瘤坏死因子受体相关因子5信号通路参与糖尿病肾病大鼠足细胞凋亡
Drug Des Devel Ther. 2018 Sep 6;12:2785-2793. doi: 10.2147/DDDT.S166525. eCollection 2018.
3
Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.黄芪甲苷通过保护链脲佐菌素诱导的糖尿病大鼠的足细胞来改善糖尿病肾病。
Eur J Pharmacol. 2014 Aug 5;736:86-94. doi: 10.1016/j.ejphar.2014.04.037. Epub 2014 May 6.
4
Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.黄芪甲苷IV通过抑制内质网应激减轻链脲佐菌素诱导的糖尿病肾病中的蛋白尿。
BMC Nephrol. 2015 Mar 31;16:44. doi: 10.1186/s12882-015-0031-7.
5
Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.黄芪甲苷通过激活 PPARγ-Klotho-FoxO1 轴抑制氧化应激来保护糖尿病肾病中的足细胞凋亡。
Life Sci. 2021 Mar 15;269:119068. doi: 10.1016/j.lfs.2021.119068. Epub 2021 Jan 18.
6
Down-regulation of PERK-ATF4-CHOP pathway by Astragaloside IV is associated with the inhibition of endoplasmic reticulum stress-induced podocyte apoptosis in diabetic rats.黄芪甲苷对PERK-ATF4-CHOP信号通路的下调作用与抑制糖尿病大鼠内质网应激诱导的足细胞凋亡有关。
Cell Physiol Biochem. 2014;33(6):1975-87. doi: 10.1159/000362974.
7
Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy.黄芪甲苷通过依赖 SERCA2 的内质网应激减少和 AMPKα 调节的自噬诱导来保护足细胞免受损伤,在链脲佐菌素诱导的糖尿病肾病中。
Sci Rep. 2017 Jul 31;7(1):6852. doi: 10.1038/s41598-017-07061-7.
8
Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.黄芪甲苷通过激活链脲佐菌素糖尿病诱导的大鼠 eNOS 来防治糖尿病肾病。
BMC Complement Altern Med. 2019 Dec 5;19(1):355. doi: 10.1186/s12906-019-2728-9.
9
Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice.黄芪甲苷通过抑制miR-21诱导的糖尿病小鼠足细胞去分化和系膜细胞活化来改善肾功能和纤维化。
Drug Des Devel Ther. 2018 Aug 6;12:2431-2442. doi: 10.2147/DDDT.S170840. eCollection 2018.
10
Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways.miR-34c的过表达通过靶向Notch信号通路抑制高糖诱导的足细胞凋亡。
Int J Clin Exp Pathol. 2015 May 1;8(5):4525-34. eCollection 2015.

引用本文的文献

1
The key role of miR‑378 in kidney diseases (Review).miR-378在肾脏疾病中的关键作用(综述)
Mol Med Rep. 2025 Apr;31(4). doi: 10.3892/mmr.2025.13466. Epub 2025 Feb 21.
2
Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy.针对糖尿病肾病中的程序性细胞死亡:从分子机制到药物治疗
Mol Med. 2024 Dec 20;30(1):265. doi: 10.1186/s10020-024-01020-5.
3
Radix Astragali and Its Representative Extracts for Diabetic Nephropathy: Efficacy and Molecular Mechanism.黄芪及其提取物治疗糖尿病肾病的疗效及分子机制。
J Diabetes Res. 2024 Sep 14;2024:5216113. doi: 10.1155/2024/5216113. eCollection 2024.
4
Identification and validation of disulfidptosis-related gene signatures and their subtype in diabetic nephropathy.糖尿病肾病中双硫死亡相关基因特征及其亚型的鉴定与验证
Front Genet. 2023 Nov 6;14:1287613. doi: 10.3389/fgene.2023.1287613. eCollection 2023.
5
Mechanisms and efficacy of traditional Chinese herb monomers in diabetic kidney disease.中药单体治疗糖尿病肾病的机制与疗效。
Int Urol Nephrol. 2024 Feb;56(2):571-582. doi: 10.1007/s11255-023-03703-0. Epub 2023 Aug 8.
6
High miR-126-3p levels associated with cardiovascular events in a general population.高 miR-126-3p 水平与普通人群中的心血管事件相关。
Eur J Intern Med. 2023 Jul;113:49-56. doi: 10.1016/j.ejim.2023.04.013. Epub 2023 Apr 18.
7
The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications.黄芪甲苷治疗糖尿病及其并发症的抗炎作用的分子基础。
Drug Des Devel Ther. 2023 Mar 10;17:771-790. doi: 10.2147/DDDT.S399423. eCollection 2023.
8
Epigenetics and endoplasmic reticulum in podocytopathy during diabetic nephropathy progression.糖尿病肾病进展过程中足细胞病的表观遗传学和内质网。
Front Immunol. 2022 Dec 22;13:1090989. doi: 10.3389/fimmu.2022.1090989. eCollection 2022.
9
Ameliorating role of microRNA-378 carried by umbilical cord mesenchymal stem cells-released extracellular vesicles in mesangial proliferative glomerulonephritis.携带脐带间充质干细胞来源的外泌体的 microRNA-378 在系膜增生性肾小球肾炎中的改善作用。
Cell Commun Signal. 2022 Mar 9;20(1):28. doi: 10.1186/s12964-022-00835-1.
10
miR-543 regulates high glucose-induced fibrosis and autophagy in diabetic nephropathy by targeting TSPAN8.miR-543 通过靶向 TSPAN8 调节高糖诱导的糖尿病肾病纤维化和自噬。
BMC Nephrol. 2022 Mar 4;23(1):89. doi: 10.1186/s12882-022-02716-8.